Pietrantonio F - Search Results

1

ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series.

Ambrosini M, Del Re M, Manca P, Hendifar A, Drilon A, Harada G, Ree AH, Klempner S, Mælandsmo GM, Flatmark K, Russnes HG, Cleary JM, Singh H, Sottotetti E, Martinetti A, Randon G, Sartore-Bianchi A, Capone I, Milione M, Di Bartolomeo M, Pietrantonio F. Ambrosini M, et al. Among authors: pietrantonio f. JCO Precis Oncol. 2022 Apr;6(1):e2200015. doi: 10.1200/PO.22.00015. JCO Precis Oncol. 2022. PMID: 35476549 Free PMC article.

2

Acute immune-mediated thrombocytopenia due to oxaliplatin administration: a case report.

Pietrantonio F, Di Bartolomeo M, Buzzoni R, Bajetta E. Pietrantonio F, et al. Tumori. 2010 Jan-Feb;96(1):154-6. doi: 10.1177/030089161009600125. Tumori. 2010. PMID: 20437874

3

Role of the antiangiogenic agent bevacizumab in the treatment of elderly patients with metastatic colorectal cancer.

Di Bartolomeo M, Pietrantonio F, Martinetti A, Buzzoni R, Gevorgyan A, Bajetta E. Di Bartolomeo M, et al. Among authors: pietrantonio f. Drugs Aging. 2011 Feb 1;28(2):83-91. doi: 10.2165/11584710-000000000-00000. Drugs Aging. 2011. PMID: 21155618 Review.

4

Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer.

Platania M, Agustoni F, Formisano B, Vitali M, Ducceschi M, Pietrantonio F, Zilembo N, Gelsomino F, Pusceddu S, Buzzoni R. Platania M, et al. Among authors: pietrantonio f. Target Oncol. 2011 Sep;6(3):181-6. doi: 10.1007/s11523-011-0185-6. Epub 2011 Jun 11. Target Oncol. 2011. PMID: 21667119

5

Hepatic colorectal cancer metastases showing a distinctive pattern of pathological response after metronomic capecitabine and bevacizumab.

Pietrantonio F, Biondani P, Pellegrinelli A, Marchianò A, Dotti KF, Buzzoni R, Di Bartolomeo M. Pietrantonio F, et al. Med Oncol. 2012 Dec;29(4):2838-41. doi: 10.1007/s12032-011-0132-5. Epub 2012 Jan 21. Med Oncol. 2012. PMID: 22271433

6

Bax expression is predictive of favorable clinical outcome in chemonaive advanced gastric cancer patients treated with capecitabine, oxaliplatin, and irinotecan regimen.

Pietrantonio F, Biondani P, de Braud F, Pellegrinelli A, Bianchini G, Perrone F, Formisano B, Di Bartolomeo M. Pietrantonio F, et al. Transl Oncol. 2012 Jun;5(3):155-9. doi: 10.1596/tlo.12151. Epub 2012 Jun 1. Transl Oncol. 2012. PMID: 22741034 Free PMC article.

7

Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients.

Pietrantonio F, Biondani P, Milione M, Melotti F, Bertarelli G, Perrone F, de Braud F, Mariani L, Fanetti G, Cortinovis D, Di Bartolomeo M. Pietrantonio F, et al. Clin Transl Oncol. 2013 Jul;15(7):582-6. doi: 10.1007/s12094-012-0971-3. Epub 2012 Nov 21. Clin Transl Oncol. 2013. PMID: 23180349 Clinical Trial.

8

Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?

Bampo C, Alessi A, Fantini S, Bertarelli G, de Braud F, Bombardieri E, Valvo F, Crippa F, Di Bartolomeo M, Mariani L, Milione M, Biondani P, Avuzzi B, Chiruzzi C, Pietrantonio F. Bampo C, et al. Among authors: pietrantonio f. Oncology. 2013;84(4):191-9. doi: 10.1159/000345601. Epub 2013 Jan 15. Oncology. 2013. PMID: 23328390 Clinical Trial.

9

Chronomodulated capecitabine and adjuvant radiation in intermediate-risk to high-risk rectal cancer: a phase II study.

Bajetta E, Pietrantonio F, Buzzoni R, Ferrario E, Valvo F, Mariani L, Dotti KF, Biondani P, Formisano B, Gevorgyan A, Grassi P, Di Bartolomeo M. Bajetta E, et al. Among authors: pietrantonio f. Am J Clin Oncol. 2014 Dec;37(6):545-9. doi: 10.1097/COC.0b013e31827ecd1d. Am J Clin Oncol. 2014. PMID: 23428953 Clinical Trial.

10

A review on biomarkers for prediction of treatment outcome in gastric cancer.

Pietrantonio F, De Braud F, Da Prat V, Perrone F, Pierotti MA, Gariboldi M, Fanetti G, Biondani P, Pellegrinelli A, Bossi I, Di Bartolomeo M. Pietrantonio F, et al. Anticancer Res. 2013 Apr;33(4):1257-66. Anticancer Res. 2013. PMID: 23564763 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters